# Zevra Therapeutics, Inc. (ZVRA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ZVRA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 75.88M | $ 46.64M | $ 22.92M | $ 1.50M | $ 217.65M |
| 2025 | $ 109.02M | $ 85.22M | $ -2.49M | $ 63.21M | $ 154.66M |
| 2024 | $ 24.82M | $ -110.90M | $ -73.22M | $ 60.30M | $ 39.67M |
| 2023 | $ 30.01M | $ -44.67M | $ -36.58M | $ 43.77M | $ 61.86M |
| 2022 | $ 11.68M | $ -46.41M | $ -21.01M | $ 18.78M | $ 75.12M |
| 2021 | $ 34.05M | $ -10.17M | $ 12.29M | $ 1.61M | $ 127.12M |
| 2020 | $ 16.93M | $ -16.26M | $ -2.51M | $ 70.55M | $ -66.41M |
| 2019 | $ 16.57M | $ -32.10M | $ -30.67M | $ 79.53M | $ -74.46M |
| 2018 | $ 0 | $ -74.57M | $ -71.61M | $ 82.05M | $ -66.57M |
| 2017 | $ 0 | $ -52.94M | $ -44.83M | $ 93.48M | $ -57.52M |
| 2016 | $ 0 | $ -24.31M | $ -41.85M | $ 91.98M | $ -18.70M |
| 2015 | $ 0 | $ -76.76M | $ -28.65M | $ 23.10M | $ -10.12M |
| 2014 | $ 0 | $ -34.55M | $ -20.80M | $ 18.95M | $ -24.30M |
| 2013 | $ 0 | $ -2.62M | $ -1.93M | $ 3.97M | $ -5.32M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.39 |
| Current Ratio | 5.17 |

## Other views

- [Metrics](https://sponda.capital/en/ZVRA.md)
- [Charts](https://sponda.capital/en/ZVRA/charts.md)
- [Compare](https://sponda.capital/en/ZVRA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-28.